How to take the Indian version of Platinib

The Indian version of Pralsetinib (Pralsetinib) is basically the same as the conventional version in terms of administration method and dosage. The Indian version of Platinib belongs to the category of generics, and its pharmaceutical ingredients are basically the same as those of the original drug, but they are different from the original drug in terms of the manufacturer.

As a potent and selective RET inhibitor, platinib is used to treat patients with RET gene fusion-positive locally advanced or metastatic non-small cell lung cancer (NSCLC), advanced or metastatic RET-mutated medullary thyroid cancer (MTC), and RET fusion-positive thyroid cancer (TC). Regarding the dosage of the Indian version of platinib, the recommended dosage is also 400 mg once a day, taken orally on an empty stomach. This means that you should avoid eating for at least 2 hours before taking the medicine and for at least 1 hour after taking the medicine. This method of administration helps ensure that the medication is fully absorbed and utilized.

For the Indian version of Platinib, the specific brand and specifications may be different, but generally speaking, the common specifications are 100mg 60 capsules or 100mg 120 capsules. Based on a daily dose of 400 mg, patients need to take 4 tablets each time. As with the regular version, if you miss a dose of the Indian version of Platinib, you can take it as soon as possible that day, but the next dose should still be taken at the original scheduled interval. If you experience vomiting after taking a dose, you should not take a missed dose but continue with the next dose as originally planned.

In addition, patients also need to be aware of some potential side effects and precautions while taking the Indian version of Platinib. The most common adverse reactions may include fatigue, constipation, musculoskeletal pain, and hypertension. If these symptoms occur, you should report it to your doctor promptly and seek medical advice.